A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, according to the findings of a UCL (University College London) and Great Ormond Street Hospital-led international clinical trial. In a paper published in The New England Journal of Medicine, researchers found that children with Dravet syndrome had up to 91% fewer seizures while being regularly administered a new medication called zorevunersen.
This article was originally published on MedicalXpress.com
